ARTICLE | Clinical News
Solbec Pharmaceuticals Ltd preclinical data
October 24, 2005 7:00 AM UTC
In a mouse model of mesothelioma, Coramsine plus CpG significantly reduced tumor growth rates (p=0.002). Six of the 15 mice treated with Coramsine plus CpG had complete regression and all 6 were immun...